Mobix Labs, Inc: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 12, 2026 and accepted by EDGAR at Feb 12, 2026, 21:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-10-01 to 2025-12-31 | $1.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-10-01 to 2025-12-31 | $1.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-10-01 to 2025-12-31 | $581.0k | us-gaap:GrossProfit |
| Research and development | 3 months2025-10-01 to 2025-12-31 | $442.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-10-01 to 2025-12-31 | $9.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | −$8.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-10-01 to 2025-12-31 | $1.4m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-10-01 to 2025-12-31 | −$24.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | −$10.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | −$0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | −$0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 63,058,761 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-10-01 to 2025-12-31 | −$4.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-12-31 | $268.0k | us-gaap:Cash |
| Current assets | At period end2025-12-31 | $2.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $32.7m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $25.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $28.1m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $1.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-12-31 | $4.3m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $4.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-006406. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.